Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)
Industry: Healthcare

OFF LIST - 797 consecutive market days: OFF LIST as of 04/05/2013 Through 11/14/2016

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company's lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a partnership with Thermo Fisher Scientific Pharma Services for the commercial production of EXPAREL. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.

Current Quote*
Last: $39.960
Change: -0.830
Book: $4.956
Volume: 190,738

As Of: 03/20 13:36 ET
*Quotes delayed by 20min.

Graphs for PCRX

3 Month Graph

6 Month Graph

1 Year Graph